Short-form notice for CuraDia's pre-pilot stage. We expect to expand this after formal legal and privacy counsel review.
Our commitment
CuraDia targets WCAG 2.1 AA across patient and clinician surfaces.
Testing methodology
We use automated checks, keyboard-only review, and screen reader review with VoiceOver and NVDA as the product matures.
Known limitations
None are documented at this time. Limitations will be listed here transparently as discovered.
Reporting an issue
Accessibility issues may be reported to info@curadia.ca, which routes to the CuraDia team.
Last reviewed
May 11, 2026. This statement is intended to be reviewed quarterly.